SCHEMBL12366272

SCHEMBL12366272

[C-]#[N+]c1c(C(F)(F)F)cc(-c2ccccc2)n(Cc2ccccc2C(F)(F)F)c1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRA P19793 2/20 0.42
NR1H2 P55055 2/20 0.42
NR1H3 Q13133 2/20 0.42
TDP1 Q9NUW8 3/20 0.41
KDM4E B2RXH2 5/20 0.39
ALDH1A1 P00352 5/20 0.39
RECQL P46063 1/20 0.39
ATM Q13315 2/20 0.39
C5AR1 P21730 2/20 0.38
NPSR1 Q6W5P4 2/20 0.38
CHRM5 P08912 1/20 0.37
KMT2A Q03164 1/20 0.37
FABP3 P05413 1/20 0.37
FABP4 P15090 1/20 0.37
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA9 Q16790 1/20 0.37
MAPT P10636 1/20 0.36
EPHX2 P34913 1/20 0.36
PPARG P37231 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12366306 0.91 RXRA (0.47) RXRANR1H2NR1H3KDM4EALDH1A1
SCHEMBL12366315 0.90 ALDH1A1 (0.48) RXRANR1H2NR1H3KDM4EALDH1A1
SCHEMBL12366439 0.90 RXRA (0.40) RXRANR1H2NR1H3TDP1KDM4E
SCHEMBL12366218 0.90 ALDH1A1 (0.41) RXRANR1H2NR1H3TDP1KDM4E
SCHEMBL12366281 0.89 MDM2 (0.40) RXRANR1H2NR1H3TDP1KDM4E
SCHEMBL12366212 0.88 CNR1 (0.44) RXRANR1H2NR1H3KDM4EALDH1A1
SCHEMBL12366440 0.88 RXRA (0.43) RXRANR1H2NR1H3KDM4EALDH1A1
SCHEMBL12366488 0.88 RXRA (0.39) RXRANR1H2NR1H3KDM4EALDH1A1
SCHEMBL12366502 0.87 RXRA (0.46) RXRANR1H2NR1H3TDP1KDM4E
SCHEMBL12366432 0.87 RXRA (0.38) RXRANR1H2NR1H3TDP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7998986-B2 Heterocyclic compounds, in particular N-substituted pyridones for modulating the activity of nuclear receptors EXELIXIS PATENT COMPANY LLC (US) 2011-08-16 US disclosed